About N-(1-cyclohexyl-1,2,4-triazol-3-yl)-2-(3-methyl-2-oxo-1-pyridinyl)acetamide
N-(1-cyclohexyl-1,2,4-triazol-3-yl)-2-(3-methyl-2-oxo-1-pyridinyl)acetamide (PubChem CID 126788056) has the molecular formula C16H21N5O2
and a molecular weight of 315.38 g/mol. Its IUPAC name is N-(1-cyclohexyl-1,2,4-triazol-3-yl)-2-(3-methyl-2-oxo-1-pyridinyl)acetamide.
Analyze N-(1-cyclohexyl-1,2,4-triazol-3-yl)-2-(3-methyl-2-oxo-1-pyridinyl)acetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-(1-cyclohexyl-1,2,4-triazol-3-yl)-2-(3-methyl-2-oxo-1-pyridinyl)acetamide?
The IUPAC name of N-(1-cyclohexyl-1,2,4-triazol-3-yl)-2-(3-methyl-2-oxo-1-pyridinyl)acetamide (CID 126788056) is N-(1-cyclohexyl-1,2,4-triazol-3-yl)-2-(3-methyl-2-oxo-1-pyridinyl)acetamide.
What is the SMILES notation for N-(1-cyclohexyl-1,2,4-triazol-3-yl)-2-(3-methyl-2-oxo-1-pyridinyl)acetamide?
The canonical SMILES for N-(1-cyclohexyl-1,2,4-triazol-3-yl)-2-(3-methyl-2-oxo-1-pyridinyl)acetamide is Cc1cccn(CC(=O)Nc2ncn(C3CCCCC3)n2)c1=O.
What is the InChIKey of N-(1-cyclohexyl-1,2,4-triazol-3-yl)-2-(3-methyl-2-oxo-1-pyridinyl)acetamide?
The InChIKey is ORFCVTGYRUBSFC-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H21N5O2/c1-12-6-5-9-20(15(12)23)10-14(22)18-16-17-11-21(19-16)13-7-3-2-4-8-13/h5-6,9,11,13H,2-4,7-8,10H2,1H3,(H,18,19,22).
What are the key properties of N-(1-cyclohexyl-1,2,4-triazol-3-yl)-2-(3-methyl-2-oxo-1-pyridinyl)acetamide?
N-(1-cyclohexyl-1,2,4-triazol-3-yl)-2-(3-methyl-2-oxo-1-pyridinyl)acetamide has a molecular weight of 315.38 g/mol, XLogP of 1.89, 4 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1-cyclohexyl-1,2,4-triazol-3-yl)-2-(3-methyl-2-oxo-1-pyridinyl)acetamide is sourced from PubChem (CID 126788056), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).